Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Sarcoma Diagnosis and Treatment, COVID-19 and healthcare impacts, Gastrointestinal Tumor Research and Treatment, and Neuroendocrine Tumor Research Advances.
Enhancing patient-centered care with AI: a study of responses to neuroendocrine neoplasms queries
Extended molecular profiling in mesenchymal tumors: a consensus paper from the Italian Sarcoma Group
<sup>18</sup>F-Fluorodeoxyglucose Uptake in <i>PDGFRA</i>-Mutant Gastrointestinal Stromal Tumors
Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG)
Clinical recommendations for treatment of localized angiosarcoma: A consensus paper by the Italian Sarcoma Group
The observational EURACAN prospective clinical registry dedicated to epithelioid hemangioendothelioma: The protocol of an international and collaborative effort on an ultra-rare entity
Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registry
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry
Guideline-Based Follow-Up Outcomes in Patients With Gastrointestinal Stromal Tumor With Low Risk of Recurrence
Corrigendum to ‘Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study’ [Eur J Cancer 171 (2022) 183–192]
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study
Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study
Time-Dependent COVID-19 Mortality in Patients With Cancer
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry
Determinants of enhanced vulnerability to COVID-19 in UK cancer patients: a European Study
UCL Discovery (University College London) 2021cited by 0position: middle
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy